Marcus Hompesch

University of Düsseldorf, Medical School. Training in Internal Medicine with particular interest in and focus on Diabetology, Diabetes Management and Clinical Research. After clinical and academic years transition into the clinical research industry. Taking entrepreneurial roles, initially focused on diabetes disease management software. Since 2000 exclusively involved in establishing and managing specialized, quality and science driven clinical research organizations, focused on early phase diabetes, MASH / MASLD, obesity drug and device development and patient engagement programs. Specialties: Early phase clinical drug and device development in Diabetes, MASH / MASLD and Obesity. Scientific expertise in designing phase 1 and 2 clinical studies with particular emphasis on meaningful (decision enabling) mechanistic and proof of concept studies.